Reviews Synera


No reviews yet.

Synera Drug Description
Synera®
(lidocaine 70 mg and tetracaine 70 mg) Topical Patch
DRUG DESCRIPTION
Synera® consists of a thin, uniform layer of a local anesthetic formulation
with an integrated, oxygen-activated heating component that is intended to enhance
the delivery of the local anesthetic. The drug formulation is an emulsion in
which the oil phase is a eutectic mixture of lidocaine 70 mg and tetracaine
70 mg. The eutectic mixture has a melting point below room temperature and therefore
exists as a liquid oil rather than as crystals. The surface area of the entire
Synera patch is approximately 50 cm2, 10 cm2 of which is active.
Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), has an octanol:water partition ratio of 182 at pH 7.3 and has the following structure:








Tetracaine is chemically designated as 2-(dimethylamino)ethyl p-(butylamino)benzoate, has an octanol:water partition ratio of 5370 at pH 7.3 and has the following structure:








Each Synera patch contains lidocaine 70 mg and tetracaine 70 mg in a eutectic mixture. The Synera formulation also contains the following inactive ingredients: polyvinyl alcohol, sorbitan monopalmitate, water, methylparaben and propylparaben.
The Synera heating component generates a mild warming that is intended to enhance the delivery of the local anesthetic. Synera begins to heat once the patch is removed from the pouch and is exposed to oxygen in the air. Although the patch may increase skin temperature by up to approximately 5ºC, maximum skin temperature will not exceed 40ºC. The heating component is composed of iron powder, activated carbon, sodium chloride, wood flour, water and filter paper.
Last reviewed on RxList: 1/23/2009




Synera Drug Description
Synera®
(lidocaine 70 mg and tetracaine 70 mg) Topical Patch
DRUG DESCRIPTION
Synera® consists of a thin, uniform layer of a local anesthetic formulation
with an integrated, oxygen-activated heating component that is intended to enhance
the delivery of the local anesthetic. The drug formulation is an emulsion in
which the oil phase is a eutectic mixture of lidocaine 70 mg and tetracaine
70 mg. The eutectic mixture has a melting point below room temperature and therefore
exists as a liquid oil rather than as crystals. The surface area of the entire
Synera patch is approximately 50 cm2, 10 cm2 of which is active.
Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), has an octanol:water partition ratio of 182 at pH 7.3 and has the following structure:








Tetracaine is chemically designated as 2-(dimethylamino)ethyl p-(butylamino)benzoate, has an octanol:water partition ratio of 5370 at pH 7.3 and has the following structure:








Each Synera patch contains lidocaine 70 mg and tetracaine 70 mg in a eutectic mixture. The Synera formulation also contains the following inactive ingredients: polyvinyl alcohol, sorbitan monopalmitate, water, methylparaben and propylparaben.
The Synera heating component generates a mild warming that is intended to enhance the delivery of the local anesthetic. Synera begins to heat once the patch is removed from the pouch and is exposed to oxygen in the air. Although the patch may increase skin temperature by up to approximately 5ºC, maximum skin temperature will not exceed 40ºC. The heating component is composed of iron powder, activated carbon, sodium chloride, wood flour, water and filter paper.
Last reviewed on RxList: 1/23/2009




Synera Drug Description
Synera®
(lidocaine 70 mg and tetracaine 70 mg) Topical Patch
DRUG DESCRIPTION
Synera® consists of a thin, uniform layer of a local anesthetic formulation
with an integrated, oxygen-activated heating component that is intended to enhance
the delivery of the local anesthetic. The drug formulation is an emulsion in
which the oil phase is a eutectic mixture of lidocaine 70 mg and tetracaine
70 mg. The eutectic mixture has a melting point below room temperature and therefore
exists as a liquid oil rather than as crystals. The surface area of the entire
Synera patch is approximately 50 cm2, 10 cm2 of which is active.
Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), has an octanol:water partition ratio of 182 at pH 7.3 and has the following structure:








Tetracaine is chemically designated as 2-(dimethylamino)ethyl p-(butylamino)benzoate, has an octanol:water partition ratio of 5370 at pH 7.3 and has the following structure:








Each Synera patch contains lidocaine 70 mg and tetracaine 70 mg in a eutectic mixture. The Synera formulation also contains the following inactive ingredients: polyvinyl alcohol, sorbitan monopalmitate, water, methylparaben and propylparaben.
The Synera heating component generates a mild warming that is intended to enhance the delivery of the local anesthetic. Synera begins to heat once the patch is removed from the pouch and is exposed to oxygen in the air. Although the patch may increase skin temperature by up to approximately 5ºC, maximum skin temperature will not exceed 40ºC. The heating component is composed of iron powder, activated carbon, sodium chloride, wood flour, water and filter paper.
Last reviewed on RxList: 1/23/2009




Synera Drug Description
Synera®
(lidocaine 70 mg and tetracaine 70 mg) Topical Patch
DRUG DESCRIPTION
Synera® consists of a thin, uniform layer of a local anesthetic formulation
with an integrated, oxygen-activated heating component that is intended to enhance
the delivery of the local anesthetic. The drug formulation is an emulsion in
which the oil phase is a eutectic mixture of lidocaine 70 mg and tetracaine
70 mg. The eutectic mixture has a melting point below room temperature and therefore
exists as a liquid oil rather than as crystals. The surface area of the entire
Synera patch is approximately 50 cm2, 10 cm2 of which is active.
Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), has an octanol:water partition ratio of 182 at pH 7.3 and has the following structure:








Tetracaine is chemically designated as 2-(dimethylamino)ethyl p-(butylamino)benzoate, has an octanol:water partition ratio of 5370 at pH 7.3 and has the following structure:








Each Synera patch contains lidocaine 70 mg and tetracaine 70 mg in a eutectic mixture. The Synera formulation also contains the following inactive ingredients: polyvinyl alcohol, sorbitan monopalmitate, water, methylparaben and propylparaben.
The Synera heating component generates a mild warming that is intended to enhance the delivery of the local anesthetic. Synera begins to heat once the patch is removed from the pouch and is exposed to oxygen in the air. Although the patch may increase skin temperature by up to approximately 5ºC, maximum skin temperature will not exceed 40ºC. The heating component is composed of iron powder, activated carbon, sodium chloride, wood flour, water and filter paper.
Last reviewed on RxList: 1/23/2009




Synera Drug Description
Synera®
(lidocaine 70 mg and tetracaine 70 mg) Topical Patch
DRUG DESCRIPTION
Synera® consists of a thin, uniform layer of a local anesthetic formulation
with an integrated, oxygen-activated heating component that is intended to enhance
the delivery of the local anesthetic. The drug formulation is an emulsion in
which the oil phase is a eutectic mixture of lidocaine 70 mg and tetracaine
70 mg. The eutectic mixture has a melting point below room temperature and therefore
exists as a liquid oil rather than as crystals. The surface area of the entire
Synera patch is approximately 50 cm2, 10 cm2 of which is active.
Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), has an octanol:water partition ratio of 182 at pH 7.3 and has the following structure:








Tetracaine is chemically designated as 2-(dimethylamino)ethyl p-(butylamino)benzoate, has an octanol:water partition ratio of 5370 at pH 7.3 and has the following structure:








Each Synera patch contains lidocaine 70 mg and tetracaine 70 mg in a eutectic mixture. The Synera formulation also contains the following inactive ingredients: polyvinyl alcohol, sorbitan monopalmitate, water, methylparaben and propylparaben.
The Synera heating component generates a mild warming that is intended to enhance the delivery of the local anesthetic. Synera begins to heat once the patch is removed from the pouch and is exposed to oxygen in the air. Although the patch may increase skin temperature by up to approximately 5ºC, maximum skin temperature will not exceed 40ºC. The heating component is composed of iron powder, activated carbon, sodium chloride, wood flour, water and filter paper.
Last reviewed on RxList: 1/23/2009





Other reviews about Synera on wordpress

Pre-trip: Arenys de Mar
  by guerson
Since we only have a few more months left before we go back to Canada, I decided it’s about time we explore a bit more of Catalunya. The […]


iLuminate Aims To Enable Exploratory Analytics
  by Merv Adrian
iLuminate 4.0 has just been released, and its parent firm, Illuminate, is ramping a campaign to join the “new analytic DBMS” party. With a very different architecture based […]


Transdermal Patches and MRIs
  by Laura
Have you heard about transdermal patches and MRIs? It is said that many of these patches have Aluminum in them that help pull the medication  into the skin. […]



Other reviews about Synera on web:

Peel-and-stick SYNERA ® is a topical anesthetic patch designed to help numb intact skin prior to minor needle procedures and is approved ... SYNERA® HOMEPAGE: TOPICAL ANALGESIC PATCH


Accurate, FDA approved Synera information for healthcare professionals and patients - brought to you by Drugs.com. Synera Official FDA information, side effects and uses.


Learn about the prescription medication Synera (Lidocaine and Tetracaine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Synera (Lidocaine and Tetracaine) Drug Information: Uses, Side ...


Synera (lidocaine/tetracaine) is used to numb the skin before certain medical procedures. Includes Synera side effects, interactions and indications. Synera Information from Drugs.com


Peel-and-stick SYNERA ® is a topical anesthetic patch designed to provide local dermal analgesia for superficial venous access procedures, approved for kids aged 3 and ... SYNERA® HOMEPAGE: TOPICAL ANALGESIC PATCH


Lidocaine with tetracaine (Synera) Molindone (Moban) Oxycodone with acetaminophen (Percocet, Endocet) Oxycodone with aspirin ; Oxymorphone (Opana) Source: References Endo Pharmaceuticals - Wikipedia, the free encyclopedia


Synera Information, Learn About Synera, Synera Forums, How to Take Synera, Synera Side Effects, Synera Interactions, Discussion Threads, Medication Warnings, Synera Overdose ... Synera - The People's Medicine Community


Ph 61 3 9530 5827 Fax 61 3 9530 5807 Mobile 0410 601 589 108 Roslyn Street Brighton Victoria 3186 Australia Synera Design Consultants Home


Synera Systems company profile in Bloomington, MN. Our free company profile report for Synera Systems includes business information such as contact, sales and financial data. Synera Systems (Synera Solutions) - Bloomington, Minnesota (MN ...





Featured Reviews

Reviews Buprenex

Buprenex Drug Description Buprenex® (buprenorphine hydrochloride) Injectable DRUG DESCRIPTION What are the possible side effects of buprenorphine injection (Buprenex)? Like other narcotic medicines, buprenorphine injection...
Read More  |  Review This
Reviews Aliskiren Tablets

Tekturna Drug Description Tekturna (aliskiren) Tablets, Oral WARNING AVOID USE IN PREGNANCY When pregnancy is detected, discontinue Tekturna as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury...
Read More  |  Review This
Reviews Fluorescein Injection

Ak-Fluor Drug Description AK-FLUOR® (fluorescein) Injection, USP 10% & 25% Sterile Solution DRUG DESCRIPTION AK-FLUOR® (Fluorescein Injection, USP) is a sterile solution in Water for Injection, of Fluorescein prepared with...
Read More  |  Review This
Reviews Synera

Synera Drug Description Synera® (lidocaine 70 mg and tetracaine 70 mg) Topical Patch DRUG DESCRIPTION Synera® consists of a thin, uniform layer of a local anesthetic formulation with an integrated, oxygen-activated heating component...
Read More  |  Review This
Reviews Ketorolac Tromethamine

Acular Drug Description ACULAR® (ketorolac tromethamine) Ophthalmic Solution 0.5% Sterile DRUG DESCRIPTION What are the possible side effects of ketorolac ophthalmic (Acular, Acular LS, Acular PF)? Get emergency medical help...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....